Hematology
Non-O Blood Type Cancer Patients Face Higher Risk of Developing Thrombosis
Venous thromboembolism includes deep-vein thrombosis (DVT), a blood clot that typically forms in the deep veins of the leg, and pulmonary embolism (PE), a life-threatening condition that occurs when a blood clot breaks free and becomes lodged in the arteries of the lung. More...19 Apr 2022
Portable Point-of-Care (POC) Device to Monitor Blood Ammonia in Liver Disease Patients
Versantis AG (Zurich, Switzerland) is developing a prototype POC device named TS-01 based on the polymersome-based ammonia quantification method. TS-01 is a unique point-of-care diagnostic device for at-home measurement of ammonia in blood, the primary cause of hepatic encephalopathy (HE). More...15 Apr 2022
Primary Graft Failure Identified by Early Chimerism Following DCBU Transplantation
Umbilical cord blood transplantation (UCBT) has increased access to potentially curative therapy for patients with life-threatening disorders of the bone marrow and immune system. The introduction of reduced intensity conditioning (RIC) regimens and double umbilical cord unit infusions (DUCBT) has broadened the applicability of UCBT to frailer or larger recipients. More...14 Apr 2022
Blood Test Proves Highly Accurate in Detecting Multiple Cancers in Early Stage
Guardant Health, Inc. (Redwood City, CA, USA) has announced new data demonstrating the ability of the company’s investigational next-generation Guardant SHIELD multi-cancer assay to accurately detect early-stage cancers. More...13 Apr 2022
First-of-Its-Kind Molecular Karyotyping Test Assists Hematologists in Diagnosing Leukemia
A new test kit can evaluate copy number aberrations (CNAs) in bone marrow cells and/or circulating cell-free DNA (cfDNA) via shallow whole-genome sequencing (sWGS), in combination with conventional cytogenetics technologies, to make leukemia diagnosis, molecular subtyping, prognostic stratification and treatment response monitoring more precise and comprehensive. More...11 Apr 2022
Blood Tests for Detecting Antioxidant and Inflammation Levels Could Diagnose Breast Cancer
Breast cancer is the most prevalent cancer in the world. Identifying new diagnostic techniques is of major importance to efforts that aim to minimize the disease’s devastating effects. Now, a new study that analyzes levels of antioxidants and stress markers in the blood could lead to a new diagnostic tool for breast cancer. More...07 Apr 2022
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Thyroid Test
Anti-Thyroid EIA Test
New
Slide Scanner System
NanoZoomer S540MD
In Other News
Blood Products Use in Trauma-Related Hemorrhagic Shock Patients Questioned
Deep Sequencing of CD34+ Cells Detects Measurable Residual Disease in AML
Flow Cytometric Immunophenotyping Assessed for Classic Hodgkin Lymphoma
First Non-Invasive Blood-Based Test Has Potential to Accurately Diagnose Alzheimer's Disease
Biomarker Panel for Risk of Early Respiratory Failure Following Hematopoietic Cell Transplantation
Novel Blood Test Could Cut Hospital Stays for Children with Cancer
Personalized Blood Test Can Detect Persistent Lung Cancer
New Technique Improves Detection of Cancer DNA in Blood
Capillary and Venous Blood Sampling Compared for Coagulation Assays
Mindray Launches BC-700 Series Integrated CBC and ESR Hematology Analyzer for Small-to-Mid Sized Labs
New One-Stage Factor VIII Assay Evaluated
Unique Diagnostic Test Based on Mass Spectrometry Technique Accurately Identifies Early-Stage Alzheimer's Disease
ELISA Blood Test Uses Innovative Biomarker to Detect Heart Disease and Sudden Cardiac Arrest
Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis
Nova Biomedical Launches CE-Marked Nova Max Pro Creatinine/eGFR Meter for Kidney Function Screening
Rapid POC Blood Ammonia Detector Could Dramatically Decrease Processing Times from Hours to Minutes
Blood Test Can Estimate Presence of Alzheimer’s Disease Changes and Blood Vessel Damage in the Brain
Algorithm Calculates Risk of Developing Prostate Cancer Using Results from Two Blood Markers
Molecular and Cytogenetic Characterization of Myelodysplastic Syndromes in Cell-Free DNA
Mitochondrial Damage May Explain the Increased Incidence of Hypertension in Black Adults
Simple Blood Test to Address Unmet Need in Alzheimer’s Disease Detection
Fujirebio Launches Neurodegeneration Assay for Automated Blood-Based Alzheimer’s Disease Biomarker Testing
First Approved Blood Test Predicts Likely Progression to Alzheimer's Up to Six Years in Advance
The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.